Amlitelimab (an anti-OX40 ligand antibody) Atopic Dermatitis (Eczema) Clinical Trial
Do you have Eczema?
OptiSkin is looking for healthy volunteers to join our paid clinical trials. Eligible volunteers with eczema will receive free biologic medication. Volunteer today and help pave the next generation of eczema treatments.
Duration
Study length is 42-44 weeks after enrollment. There are a total of 11 in-person visits required. Participants will be compensated for time and travel.
Study Specifics
For adult patients 18+ who have been diagnosed with moderate to severe eczema. Patients must be treated with Amlitelimab (an anti-OX40 ligand antibody) therapy once enrolled.
Eligibility
To participate, you MUST have:
- Severe eczema
You will NOT be eligible if:
- you have received Otezla® (apremilast) in the past
- your child is currently enrolled in another clinical trial
Additional inclusion/exclusion criteria will apply.